Q4 2023 · 13F-HR
M28 Capital Management LPholdings as filed
Filed 2024-02-12 · accession 0000902664-24-001422
$120.7M
Reported value
10
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $37.2M | 30.8% | 7,373,413 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $36.4M | 30.2% | 9,248,250 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $15.7M | 13.0% | 523,280 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $6.3M | 5.24% | 363,800 | Common | SOLE |
| 231269309 | CRIS | CURIS INC | $5.4M | 4.46% | 421,951 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $5.2M | 4.32% | 142,800 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.9M | 4.05% | 121,200 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $3.8M | 3.13% | 1,910,600 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.7M | 3.06% | 216,600 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $2.1M | 1.71% | 67,400 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.